Clik here to view.
Fujifilm Increases Production Capacity and Establishes New Process...
TOKYO FUJIFILM Corporation (President: Kenji Sukeno) will increase production capacity by investing about JPY14 billion ($130m) in the USA and UK in order to expand the business of its BioCDMO...
View ArticleClik here to view.
Geneious Biologics Set to Launch at Bio-IT World
AUCKLAND, New Zealand Geneious Biologics, a next-generation cloud service developed to empower enterprises engaged in commercial antibody discovery and screening and significantly improve their...
View ArticleClik here to view.
Simulations Plus Establishes Distribution Channel in India with Electrolab
LANCASTER, Calif. Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals...
View ArticleClik here to view.
ReplicorがNAPによるHBV/HDVの1年間の機能的制御の達成とNAPの薬理作用機序に関する新知見を公表
モントリオール （ビジネスワイヤ） — 慢性HBV/HDV感染の治療薬に絞った開発に取り組む非公開バイオ製薬企業のReplicor Inc.は本日、2017年4月19～23日にオランダのアムステルダムで開催中の2017年欧州肝臓学会（EASL）年次総会で、HBV/HDV感染におけるNAP活性に関する有意義な新データを公表しました。 REP 301（HBV/HDV同時感染）およびREP...
View ArticleClik here to view.
Replicor披露 NAP功能性控制HBV和HDV的1年成果及有关NAP药理机制的新见解
蒙特利尔 (美国商业资讯) — 致力于根治慢性HBV和HDV感染的私营生物制药公司Replicor Inc.今天在欧洲肝脏研究学会(EASL) 2017年年会上披露了有关HBV和HDV感染中NAP活性的重大新数据，此次会议于2017年4月19-23日在荷兰阿姆斯特丹召开。 REP 301（HBV/HDV合并感染）和REP 401（HBV感染）研究的更新显示重大进展： 1. REP...
View ArticleClik here to view.
Synexus提升能力成为世界领先的研究单位网络
英国曼彻斯特 (美国商业资讯) 总部位于欧洲的Synexus和总部位于美国的Radiant Research今天宣布，两家公司的运营进行完全整合，成为一个拥有185家研究单位和1,500位员工的单一全球性研究单位网络。此举将创建世界上最大的临床试验单位网络，遍及11个国家，可获取关键临床开发市场中超过1亿患者，该网络在Synexus名下运营。...
View ArticleClik here to view.
Clik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Progesterone Capsules in the...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Progesterone Capsules, 100 mg and 200 mg, a...
View ArticleClik here to view.
Samsung Bioepis Obtains First Drug Approval in the United States, as the U.S....
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved RENFLEXIS™ (infliximab-abda), a biosimilar referencing Remicade®i (infliximab),...
View ArticleClik here to view.
Synaptive Medical Receives CE Mark in Europe and Regulatory Approval in...
TORONTO Synaptive Medical Inc., a medical device and technology company, has received its first CE Mark as well as regulatory approval in Australia. The approval opens European and Australian...
View ArticleClik here to view.
Clik here to view.
EpimAb Biotherapeutics Raises $25M in Series A Financing From International...
SHANGHAI EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the completion of a $25 million Series A financing round....
View ArticleClik here to view.
AtriCure’s AtriClip System Surpasses 100,000 Units Sold Worldwide
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has sold more than...
View ArticleClik here to view.
Akebia and Otsuka Expand Relationship with Collaboration to Develop and...
CAMBRIDGE, Mass. & TOKYO Akebia Therapeutics, Inc. (NASDAQ:AKBA) and Otsuka Pharmaceutical Co., Ltd. today announced that they have expanded their collaboration for vadadustat by entering into a...
View ArticleClik here to view.
Akebia and Otsuka Expand Relationship with Collaboration to Develop and...
CAMBRIDGE, Mass. & TOKYO Akebia Therapeutics, Inc. (NASDAQ: AKBA) and Otsuka Pharmaceutical Co., Ltd. today announced that they have expanded their collaboration for vadadustat by entering into...
View ArticleClik here to view.
Corindus Announces Live Broadcast of Robotic-assisted PCI using CorPath® GRX...
WALTHAM, Mass. Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today that Fu Wai Hospital in China performed and broadcast live a PCI...
View ArticleClik here to view.
MPEG LAがCRISPR-Cas9特許の一括ライセンスでのプール化を呼び掛け
デンバー （ビジネスワイヤ） — ライセンシングの世界的リーダー企業MPEG LAは本日、CRISPR-Cas9特許の保有者に世界的なCRISPR-Cas9共同ライセンシングプラットフォーム創設への参加を呼び掛けました。本プラットフォームは、これら保有者の画期的技術への広範なアクセスを実現するためのものです。 MPEG...
View ArticleClik here to view.
Corindus宣布，采用CorPath® GRX的机器人辅助PCI向韩国召开的TCT亚太峰会直播
马萨诸塞州沃尔瑟姆 — (美国商业资讯) — 精准血管机器人的领先开发者Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS]今天宣布，中国阜外医院采用CorPath GRX系统实施了一台PCI手术，并向第22届TCT亚太心血管年度峰会的4,000多位与会者直播。此次年会在韩国首尔召开，吸引了来自44个国家的与会者，多数与会者来自亚太区。...
View ArticleClik here to view.
MPEG LA欢迎CRISPR-Cas9专利加入一站式许可平台
丹佛 (美国商业资讯)–技术许可领域的世界领导者MPEG LA, LLC今日宣布欢迎CRISPR-Cas9专利持有人参与全球CRISPR-Cas9联合许可平台的建立，该平台将有助于用户方便获得专利持有人的突破性技术。 MPEG LA总裁兼首席执行官Larry...
View ArticleAvita Medical CEO Shareholder Letter and Quarterly Report
VALENCIA, Calif. & PERTH, Australia & LONDON Today, the CEO of Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) issued the following letter to shareholders: Dear Shareholder, At the...
View Article